The Death of MONA in ACS: Part III – Nitroglycerin
Background: Nitroglycerin is a first line agent in the treatment of ACS. The physiologic basis for it’s use rests on it’s ability to promote coronary vasodilation resulting in increased blood...
Marco Torres |